Back to top

Image: Bigstock

Top Ranked Momentum Stocks to Buy for April 3rd

Read MoreHide Full Article

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, April 3rd:

electroCore, Inc. (ECOR - Free Report) : This bioelectronic medicine company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 48.7% over the last 60 days.

electroCore’s shares gained 5.1% over the last one month above the S&P 500’s decrease of 12.8%. The company possesses a Momentum Score of A.

CytomX Therapeutics, Inc. (CTMX - Free Report) : This oncology-focused biopharmaceutical company has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 25.2% over the last 60 days.

CytomX Therapeutics’ shares gained 4.2% over the last one month. The company possesses a Momentum Score of A.

DHT Holdings, Inc. (DHT - Free Report) : This crude oil tankers operator has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 41.6% over the last 60 days.

DHT’s shares gained 35% over the last one month. The company possesses a Momentum Score of A.

Aytu BioScience, Inc. : This specialty pharmaceutical company has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 3.8% over the last 60 days.

Aytu BioScience’s shares gained more than 100% over the last one month. The company possesses a Momentum Score of A.

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

Looking for Stocks with Skyrocketing Upside?

Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.     

Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.  

See the pot trades we're targeting>>                                    


In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


electroCore, Inc. (ECOR) - free report >>

DHT Holdings, Inc. (DHT) - free report >>

CytomX Therapeutics, Inc. (CTMX) - free report >>